Exam 2 (Pt. 11) Flashcards

1
Q

Amphetamine (β-phenylisoproplamine) - Adverse Effect

A
  • Dysphoria, insomnia, suicidal tendencies
  • irritability, weakness, dizziness,
  • tremor, headache, hyperactive reflexes,
  • confusion, delirium, panic stress,

Amphetamine Psychosis

  • Palpitations, anginal pain, cardiac arrhythmias,
  • hypertension, headaches, chills,
  • sweating, anorexia, nausea,
  • vomiting, abdominal cramps, diarrhea
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Amphetamine (β-phenylisoproplamine) - Therapeutic Use

A
  • Weight Control
  • Treatment of Narcolepsy
  • Paradoxical calming effects in hyperactive children
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Children with ADHD - Sign

A
  • Inattentive
  • Impulsive
  • Hyperkinetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Attention Deficit/Hyperactivity Disorder - Subtype

A
  • Inattentive
  • Predominantly hyperactive-impulsive
  • Combined
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Attention Deficit/Hyperactivity Disorder - Pharmacotherapy

A
  • Dextroamphetamine
  • Methylphenidate (Ritalin)
  • Pemoline (Cylert) FDA Withdrew in 2005
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Attention Deficit/Hyperactivity Disorder - Mechanism of Drugs

A
  • Enhanced dopaminergic function
  • Enhanced noradrenergic function
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Attention Deficit/Hyperactivity Disorder - Concerns of Drugs

A
  • Growth Retardation
  • Abuse Potential
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Nicotine - General

A
  • Second only to caffeine in use as a CNS stimulant
  • Active ingredient in tobacco
  • Has no therapeutic use
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Nicotine - Mechanism

A
  • Absorbed from oral mucosa, lungs, GI and skin
  • Low dose - ganglionic agonist
  • High dose - ganglionic blockade
  • highly Lipid soluble
  • Low dose - arousal, relaxation, improves attention, learning and reaction time
  • High doses - depress central respiratory and cardiovascular areas
  • Complex peripheral effects and action depends on dose
  • Exacerbates peripheral vascular disease and angina
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Nicotine - Dependence

A
  • Withdrawal syndrome varies in intensity between individuals
  • Onset of syndrome is usually within 24 hours
  • Symptoms include irritability, impatience, restlessness, anxiety, headaches, increased appetite, insomnia, difficulty in concentrating.
  • There is also a decrease in heart rate, blood pressure and circulating epinephrine.
  • Blood flow to the skin increases and thus skin temperature increases.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Nicotine Concentrations in Blood Resulting from Different Nicotine Delivery Systems

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Effects of Nicotine - Subjective

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Effects of Nicotine - Physiologic Effect

A

CTZ – chemoreceptor trigger zone (area postrema)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Effects of Nicotine - Withdrawal Syndrome

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Nicotine: Stimulant Effect on Heart Rate

A

The heart rate is stimulated by nicotine in a dose-dependent way. Also, the nicotine effect is stronger after overnight abstinence (color bars) than after the 1-h abstinence between the first and the second cigarettes of the day (gray bars).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Per Capita Cigarette Consumption in the United States From 1900 to 1985

A
17
Q

Relationship Between Cigarette Smoking and Death From Lung Cancer

A
19
Q

Caffeine - Mechanism

A
20
Q

Effects of Caffeine - Subjective

A
21
Q

Effects of Caffeine - Physiologic

A
22
Q

Effects of Caffeine - Withdrawal Syndrome

A
23
Q

Typical Caffeine Content of Common Food Items and Drugs

A
25
Q

Cognitive and Psychomotor Performance as a Function of Average Daily Caffeine Consumption - Conclusion

A

The results indicate a significant relationship between overall daily caffeine intake and improved performance on every task.

30
Q

Time Course of Caffeine Withdrawal Symptoms - Conclusion

A

Substitution of placebo for this low dose of caffeine produced a rapid appearance of withdrawal symptoms followed by a gradual return to normalcy over the next several days. *p 0.05 compared to the mean of the initial caffeine period.

31
Q

Glutamate Synthesis & Inactivation

A
33
Q

Caffeine - General

A
  • Caffeine is a methylxanthine
  • Most popular and widely consumed drug in the world
34
Q

Structural and Functional Properties of Glutamate Receptors

A
35
Q

Schematic Representation of the NMDA Receptor Complex

A

Diagram The NMDA receptor complex possesses a glutamate recognition site to which receptor agonists and competitive antagonists bind, as well as other binding sites for glycine, polyamines such as spermine and spermidine, phencyclidine (PCP) and related drugs, Mg2+, and Zn2+. Channel opening permits an influx of Na+ and Ca2+ ions, and efflux of K+ ions.

41
Q

Cognitive and Psychomotor Performance as a Function of Average Daily Caffeine Consumption - Procedure

A

Over 7,000 men and women in Great Britain were surveyed for information on their coffee- and tea-drinking habits and for other potentially relevant lifestyle variables. They were subsequently tested for their performance on four tasks: simple reaction time, choice reaction time, incidental verbal memory, and visuospatial reasoning.

43
Q

Time Course of Caffeine Withdrawal Symptoms - Procedure

A

The subjects of this study were seven men and women, all of whom were regular caffeine users (mean prestudy consumption was estimated to be 384 mg/day). During the study, the subjects refrained from all dietary caffeine intake

44
Q

Time Course of Caffeine Withdrawal Symptoms - Phase I

A

In the first phase (Caffeine), subjects were given 10 capsules/day, each containing 10 mg caffeine, for a total of 100 mg/day.

45
Q

Time Course of Caffeine Withdrawal Symptoms - Phase II

A

In the second phase (Placebo), the caffeine capsules were replaced with identical-looking placebo capsules; participants were aware of placebo usage but not the time it would be switched.

46
Q

Time Course of Caffeine Withdrawal Symptoms - Final Phase

A

The final phase (Caffeine) involved reexposure of subjects to 100 mg/day of caffeine.

49
Q

Criteria met by Glutamate to be considered a Neurotransmitter

A
  • It is localized presynaptically in specific neurons where it is stored and released from synaptic vesicles.
  • It is released by a calcium-dependent mechanism by physiologically relevant stimuli in amount sufficient to elicit postsynaptic response.
  • A mechanism (reuptake) exits that will rapidly terminate its transmitter action.
  • It demonstrates pharmacological identity with the naturally occurring transmitter.
  • Receptors
50
Q

Excitatory Neurotransmitters - Distribution

A

Just be aware that these excitatory neurotransmitter, especially glutamate, are very widely distributed throughout the brain.